ReviewJournal of Cancer2013

Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy.

Kalliopi Domvri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.